SCHEMBL2988721

SCHEMBL2988721

O=C(O)Cc1ccc(O)c(CN2C(=O)c3ccccc3C2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.51
▸ MEN1 O00255 3/20 0.49
▸ RGS12 O14924 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ HPGD P15428 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ GAA P10253 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ THPO P40225 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ GNAI1 P63096 1/20 0.49
▸ PMP22 Q01453 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6755812 0.88 HPGD (0.50) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL31752531 0.82 KMT2A (0.68) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL31751934 0.80 KMT2A (0.65) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL6076008 0.77 GRM5 (0.62) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL15624560 0.75 MPO (0.50) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL31753192 0.75 KMT2A (0.55) KMT2AMEN1HTTHPGDTSHR
SCHEMBL10825727 0.75 GAA (0.70) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL27766198 0.74 KMT2A (0.49) KMT2AMEN1MAPTHPGDTSHR
SCHEMBL10200857 0.74 CASP3 (0.55) KMT2AMEN1RGS12LMNAMAPT
SCHEMBL6675322 0.72 KDM4E (0.59) KMT2AMEN1LMNAHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 — — US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 — — EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 — — EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 — — US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 — — US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 — — US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 — — EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MEN1 4149/4885RGS12 1133/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 KMT2A 505/4885MEN1 4149/4885RGS12 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback